hl301
Botanicalexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2014 (NCT02250027)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hl301
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04632342 | Phase 2 | Nov 30, 2020 | Hanlim Pharm. Co., Ltd. |
| NCT03309800 | Phase 2 | Mar 29, 2017 | Hanlim Pharm. Co., Ltd. |
| NCT02250027 | Phase 2 | Mar 1, 2014 | Hanlim Pharm. Co., Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hanlim Pharm. Co., Ltd. | For profit | 3 | 3 | 1 | 2014 |
1 organizations
Page 1 / 1